Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ)

BRIEF

published on 07/16/2024 at 14:31, 4 months 6 days ago

Eckert & Ziegler augmente ses ventes et ses bénéfices et relève ses prévisions de bénéfices pour 2024

Eckert & Ziegler EBIT Prévisions De Bénéfices La Croissance Des Ventes Résultats Financiers 2024
BRIEF

published on 07/16/2024 at 14:31, 4 months 6 days ago

Eckert & Ziegler Increases Sales and Earnings, Raises Profit Forecast for 2024

Sales Growth Eckert & Ziegler EBIT Profit Forecast 2024 Financial Results
PRESS RELEASE

published on 07/16/2024 at 14:26, 4 months 6 days ago

EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024.
Eckert & Ziegler SE reports impressive sales and earnings growth in the first half of 2024. Profit forecast raised for 2024

Sales Growth Earnings Increase Profit Forecast Eckert & Ziegler SE 2024 Financial Results
BRIEF

published on 06/26/2024 at 16:32, 4 months 26 days ago

L'Assemblée générale annuelle d'Eckert & Ziegler SE approuve la scission de Pentixapharm AG

Eckert & Ziegler Dividende Scission D'entreprise Assemblée Générale Annuelle Pentixapharm AG
BRIEF

published on 06/26/2024 at 16:32, 4 months 26 days ago

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG

Annual General Meeting Dividend Eckert & Ziegler Pentixapharm AG Corporate Split-Off
PRESS RELEASE

published on 06/26/2024 at 16:27, 4 months 26 days ago

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG
The Annual General Meeting of Eckert & Ziegler SE has approved the split-off of Pentixapharm AG and declared a dividend of EUR 0.05 per share for 2023

Annual General Meeting Dividend Eckert & Ziegler SE Pentixapharm AG Split-off
BRIEF

published on 06/25/2024 at 12:05, 4 months 27 days ago

Eckert & Ziegler Subsidiary Pentixapharm Receives FDA Feedback to Initiate Phase III Trial with PentixaFor

Pentixapharm FDA Phase III Trial Ga68-PentixaFor Primary Aldosteronism Radiopharmaceutical Diagnostic
BRIEF

published on 06/25/2024 at 12:05, 4 months 27 days ago

Pentixapharm, filiale d'Eckert & Ziegler, reçoit les commentaires de la FDA pour lancer un essai de phase III avec PentixaFor

Pentixapharm Essai De Phase III De La FDA Ga68-PentixaPour Aldostéronisme Primaire Diagnostic Radiopharmaceutique
PRESS RELEASE

published on 06/25/2024 at 12:00, 4 months 27 days ago

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism
Pentixapharm, a subsidiary of Eckert & Ziegler SE, receives FDA feedback to start Phase III trial with radiopharmaceutical diagnostic Ga68-PentixaFor for Primary Aldosteronism

Eckert & Ziegler FDA Feedback Phase III Trial Pentixapharm Primary Aldosteronism
BRIEF

published on 06/19/2024 at 09:05, 5 months 3 days ago

Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility

Oncology Cancer Therapy Radiopharmaceuticals Isotope Production Actinium-225

Published on 11/22/2024 at 23:55, 3 hours 30 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 3 hours 55 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 4 hours 20 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 4 hours 20 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 4 hours 55 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 9 hours 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 9 hours 25 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 9 hours 31 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 10 hours 29 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 11 hours 25 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 9 hours 40 minutes ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 11 hours 9 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 12 hours 50 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 12 hours 50 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 1 day 20 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News